Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Han S Lee

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Muscle & Nerve|February 21, 2009
Adult nemaline myopathy with trabecular muscle fibersViktoriya S Irodenko, Han S Lee, Stephen J de Armond, et al.
Pituitary|December 24, 2014
Hypophysitis: a single-center case seriesBrandon S Imber, Han S Lee, Sandeep Kunwar, et al.
Frontiers in Immunology|February 13, 2023
TLQP-21 is a low potency partial C3aR activator on human primary macrophagesXaria X Li, John D Lee, Han S Lee, et al.
Plos One|May 5, 2012
Clinical utility of LC3 and p62 immunohistochemistry in diagnosis of drug-induced autophagic vacuolar myopathies: a case-control studyHan S Lee, Brianne H Daniels, Eduardo Salas, et al.
Pituitary|May 15, 2014
Pituicytomas and spindle cell oncocytomas: modern case series from the University of California, San FranciscoCorinna C Zygourakis, John D Rolston, Han S Lee, et al.
Advances in Ophthalmology and Optometry|September 17, 2025
Ocular Manifestations of Giant Cell ArteritisTimothy Do, Gaurav Gulati, Han S Lee, et al.
The American Journal of Surgical Pathology|May 18, 2013
LC3 and p62 as diagnostic markers of drug-induced autophagic vacuolar cardiomyopathy: a study of 3 casesBrianne H Daniels, Rodney D McComb, Bret C Mobley, et al.
Behavioral Neuroscience|October 3, 2007
Mating activates NMDA receptors in the medial preoptic area of male ratsJuan M Dominguez, Margaret E Balfour, Han S Lee, et al.
Toxins|October 25, 2024
Dysphagia and Muscle Weakness Secondary to Botulinum Toxin Type A Treatment of Cervical Dystonia: A Drug Class Analysis of Prescribing InformationKhashayar Dashtipour, Han S Lee, Aaron Ellenbogen, et al.
Toxins|April 25, 2025
Reply to Trosch et al. Comment on "Dashtipour et al. Dysphagia and Muscle Weakness Secondary to Botulinum Toxin Type A Treatment of Cervical Dystonia: A Drug Class Analysis of Prescribing Information. <i>Toxins</i> 2024, <i>16</i>, 442"Khashayar Dashtipour, Han S Lee, Aaron Ellenbogen, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Muscle & Nerve|February 21, 2009
Adult nemaline myopathy with trabecular muscle fibersViktoriya S Irodenko, Han S Lee, Stephen J de Armond, et al.
Pituitary|December 24, 2014
Hypophysitis: a single-center case seriesBrandon S Imber, Han S Lee, Sandeep Kunwar, et al.
Frontiers in Immunology|February 13, 2023
TLQP-21 is a low potency partial C3aR activator on human primary macrophagesXaria X Li, John D Lee, Han S Lee, et al.
Plos One|May 5, 2012
Clinical utility of LC3 and p62 immunohistochemistry in diagnosis of drug-induced autophagic vacuolar myopathies: a case-control studyHan S Lee, Brianne H Daniels, Eduardo Salas, et al.
Pituitary|May 15, 2014
Pituicytomas and spindle cell oncocytomas: modern case series from the University of California, San FranciscoCorinna C Zygourakis, John D Rolston, Han S Lee, et al.
Advances in Ophthalmology and Optometry|September 17, 2025
Ocular Manifestations of Giant Cell ArteritisTimothy Do, Gaurav Gulati, Han S Lee, et al.
The American Journal of Surgical Pathology|May 18, 2013
LC3 and p62 as diagnostic markers of drug-induced autophagic vacuolar cardiomyopathy: a study of 3 casesBrianne H Daniels, Rodney D McComb, Bret C Mobley, et al.
Behavioral Neuroscience|October 3, 2007
Mating activates NMDA receptors in the medial preoptic area of male ratsJuan M Dominguez, Margaret E Balfour, Han S Lee, et al.
Toxins|October 25, 2024
Dysphagia and Muscle Weakness Secondary to Botulinum Toxin Type A Treatment of Cervical Dystonia: A Drug Class Analysis of Prescribing InformationKhashayar Dashtipour, Han S Lee, Aaron Ellenbogen, et al.
Toxins|April 25, 2025
Reply to Trosch et al. Comment on "Dashtipour et al. Dysphagia and Muscle Weakness Secondary to Botulinum Toxin Type A Treatment of Cervical Dystonia: A Drug Class Analysis of Prescribing Information. <i>Toxins</i> 2024, <i>16</i>, 442"Khashayar Dashtipour, Han S Lee, Aaron Ellenbogen, et al.
Pageof 3